Savant Capital’s PetMed Express PETS Stock Holding History

Savant Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,663	Closed	-$104K	–	1323
2024 Q1	$104K	Buy	+21,663	New	+$126K	﹤0.01%	1069

Other funds holding PETS

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Savant Capital's PETS Position: Q2 2024 in Review

Savant Capital sold out of PetMed Express (PETS) in Q2 2024, closing a stake of 21,663 shares — an estimated $104K sold.

Savant Capital first reported a position in PETS in Q1 2024 and held it in 1 quarter. The position peaked at $104K in Q1 2024. 117 funds tracked by Wall St. Rank hold PETS as of Q2 2024.

Savant Capital reported no remaining PetMed Express position as of Q2 2024 after selling out during the quarter.
Savant Capital sold 21,663 PetMed Express shares in Q2 2024, an estimated $104K.
Savant Capital first reported a position in PetMed Express in Q1 2024 and held it in 1 quarter.
Savant Capital's PetMed Express position peaked at $104K in Q1 2024.
117 funds tracked by Wall St. Rank held PetMed Express as of Q2 2024.

Based on Savant Capital's 13F filing for Q2 2024, filed 5 Aug 2024.